Detailed definition
Metabolic syndrome is defined (by ATP-III/NCEP and other groups) as ≥3 of: increased waist circumference, elevated triglycerides, low HDL cholesterol, elevated blood pressure, and elevated fasting glucose. Prevalence rises sharply across the menopause transition: estrogen withdrawal favors visceral fat deposition, raises LDL cholesterol, and may worsen insulin sensitivity. Postmenopausal women lose much of the relative cardiovascular protection they had compared to age-matched men. Management is multifactorial: weight management with focus on visceral fat (resistance training, protein, dietary pattern), blood pressure control, lipid management (statins where indicated), glucose monitoring with progression to medication where needed, and lifestyle (sleep, alcohol moderation, smoking cessation). HRT initiated in the timing window has neutral-to-favorable effects on lipids (estradiol lowers LDL and raises HDL) and modestly improves insulin sensitivity, though it is not approved as a primary cardioprotective therapy.
Why it matters in menopause
The "menopause weight" conversation often misses that the visceral fat shift is metabolically meaningful, not cosmetic. Postmenopausal cardiovascular risk rises faster than premenopausal — a fact that informs why early-postmenopausal HRT, started in the timing window, has a favorable cardiovascular signal.
Related terms
Sources
External references: Wikipedia.